Linda Greub

Board Member

2024

Managing Partner

2018

Investing in Early Stage Women's Health and Life Science Ventures

Member Board Of Directors

2022

Board Observer

2019

Board Observer

2021

CEO

2016 - 2018

Life science consulting & financial advisory.

Partner

2010 - 2018

Provided seed capital to early stage companies in Life Science, Education and the Consumer Sector.

VP Corporate Development

2015 - 2016

Led partnership outreach for NGS sample enrichment technology company focused on liquid biopsy for early detection & monitoring of cancer, inherited & infectious disease. Acquired by Bio-Rad.

VP Strategy & Corporate Development

2013 - 2014

Redefined corporate strategy for ultra-sensitive protein detection technology company focused on cardiovascular disease and led efforts to sell RUO business unit.

Director Diagnostics Strategy, Business Development and M&A

2011 - 2013

Led molecular diagnostics M&A efforts within the $3B Vaccines & Infectious Disease Diagnostics Division of Novartis AG.